Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00438568 · ClinicalTrials.gov registry record · Phase 2
SNIFF 120: Study of Nasal Insulin to Fight Forgetfulness (120 Days)
A Phase 2 study, sponsored by University of Washington.
- Completed
- Registry status
- Phase 2
- Development phase
- 173
- Enrollment target
NCT00438568 is a Phase 2 study that has completed, run by University of Washington. The registered enrollment target is 173 participants.
The verdict
NCT00438568, a Phase 2 study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 173 participants
- Enrollment target
Study Summary
The purpose of this study is to find out if insulin, when administered as a "nasal spray" into the nasal passages, improves memory in adults with mild cognitive impairment (MCI) or Alzheimer's disease.
Interventions
- DRUG Placebo
- DRUG Regular Insulin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 173 participants |
| Start Date | 2006-06 |
| Est. Completion | 2011-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00438568
The ClinicalTrials.gov registry entry for NCT00438568 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 173 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00438568 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00438568 about?
NCT00438568 is a clinical study titled "SNIFF 120: Study of Nasal Insulin to Fight Forgetfulness (120 Days)". The purpose of this study is to find out if insulin, when administered as a "nasal spray" into the nasal passages, improves memory in adults with mild cognitive impairment (MCI) or Alzheimer's disease.
What is the current status of trial NCT00438568?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 173 participants. The study started on 2006-06. Estimated completion is 2011-12.
What interventions are being tested in trial NCT00438568?
The interventions under investigation include: Placebo (DRUG), Regular Insulin (DRUG).
Who is sponsoring clinical trial NCT00438568?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.